Abstract
Breaching the skin’s stratum corneum barrier raises the possibility of administration of vaccines, gene vectors, antibodies, photosensitisers and even nanoparticles, all of which have at least their initial effect on populations of skin cells. Intradermal vaccine delivery, in particular, holds enormous potential for improved therapeutic outcomes for patients, particularly those in the developing world. Various microneedle-based vaccine delivery strategies have been employed, and here we discuss each one in turn. We also describe the importance of cutaneous immunobiology on the effect produced by microneedle-mediated intradermal vaccination.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hegde, N.R., Kaveri, S.V., Bayry, J.: Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination. Drug Discov Today 16, 1061–1068 (2011)
Koutsonanos, D., del Pilar Martin, M., Zarnitsyn, V., Sullivan, S., Compans, R., Skountzou, I., et al.: Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One 4, e4773 (2009)
Nicolas, J., Guy, B.: Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 7, 1201–1214 (2008)
Warger, T., Schild, H., Rechtsteiner, G.: Initiation of adaptive immune responses by transcutaneous immunization. Immunol Lett 109, 13–20 (2007)
Stoitzner, P., Sparber, F., Tripp, C.H.: Langerhans cells as targets for immunotherapy against skin cancer. Immunol Cell Biol 88, 431–437 (2010)
Kenney, R.T., Yu, J., Guebre-Xabier, M., Frech, S.A., Lambert, A., Heller, B.A., et al.: Induction of protective immunity against lethal anthrax challenge with a patch. J Infect Dis 190, 774–782 (2004)
Combadiere, B., Vogt, A., Mahe, B., Costagliola, D., Hadam, S.: Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS One 5, e10818 (2010)
Lambert, P.H., Laurent, P.E.: Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 26, 3197–3208 (2008)
Wysocki, A.B.: Skin anatomy, physiology, and pathophysiology. Nurs Clin North Am 34, 777–797 (1999)
Chuong, C.M., Nickoloff, B.J., Elias, P.M., Goldsmith, L.A., Macher, E., Maderson, P.A., et al.: What is the ‘true’ function of skin? Exp Dermatol 11, 159–187 (2002)
Williams, A.C., Barry, B., Barry, B.W.: Skin absorption enhancers. Crit Rev Ther Drug Carrier Syst 9, 305–353 (1992)
Wiechers, J.W.: The barrier function of the skin in relation to percutaneous absorption of drugs. Pharmaceutisch weekblad Scientific 11, 185–198 (1989)
Tobin, D.: Biochemistry of human skin–our brain on the outside. Chem Soc Rev 35, 52–67 (2006)
Asbill, C.S., El Kattan, A.F., Michniak, B.: Enhancement of transdermal drug delivery: chemical and physical approaches. Crit Rev Ther Drug Carrier Syst 17, 621–658 (2000)
Menon, G.: New insights into skin structure: scratching the surface. Adv Drug Deliv Rev 54, S3–S17 (2002)
Siddiqui, O.: Physicochemical, physiological, and mathematical considerations in optimizing percutaneous absorption of drugs. Crit Rev Ther Drug Carrier Syst 6, 1–38 (1989)
Scheuplein, R.J.: Permeability of the skin: a review of major concepts. Curr Probl Dermatol 7, 172–186 (1978)
Steinman, R.M., Hawiger, D., Nussenzweig, M.C.: Tolerogenic dendritic cells. Annu Rev Immunol 21, 685–711 (2003)
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., et al.: Immunobiology of dendritic cells. Annu Rev Immunol 18, 767–811 (2000)
Kleijwegt, F.S., Jansen, D.T., Teeler, J., Joosten, A.M., Laban, S., Nikolic, T., Roep, B.O.: Tolerogenic dendritic cells impede priming of naïve CD8(+) T cells and deplete memory CD8(+) T cells. Eur J Immunol 43(1), 85–92 (2012). doi:10.1002/eji.201242879
Ginhoux, F., Ng, L.G., Merad, M.: Understanding the murine cutaneous dendritic cell network to improve intradermal vaccination strategies. Curr Top Microbiol Immunol 351, 1–24 (2012)
Teunissen, M.B., Haniffa, M., Collin, M.P.: Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design. Curr Top Microbiol Immunol 351, 25–76 (2012)
Steinman, R.M., Hemmi, H.: Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 311, 17–58 (2006)
Merad, M., Ginhoux, F., Collin, M.: Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8, 935–947 (2008)
Romani, N., Clausen, B.E., Stoitzner, P.: Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev 234, 120–141 (2010)
Takahara, K., Omatsu, Y., Yashima, Y., Maeda, Y., Tanaka, S., Iyoda, T., et al.: Identification and expression of mouse Langerin (CD207) in dendritic cells. Int Immunol 14, 433–444 (2002)
Valladeau, J., Saeland, S.: Cutaneous dendritic cells. Semin Immunol 17, 273–283 (2005)
Steinman, R.M., Nussenzweig, M.C.: Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. U. S. A. 99, 351–358 (2002)
Larregina, A.T., Falo Jr., L.D.: Changing paradigms in cutaneous immunology: adapting with dendritic cells. J Invest Dermatol 124, 1–12 (2005)
Bursch, L.S., Wang, L., Igyarto, B., Kissenpfennig, A., Malissen, B., Kaplan, D.H., et al.: Identification of a novel population of Langerin + dendritic cells. J Exp Med 204, 3147–3156 (2007)
Ginhoux, F., Collin, M.P., Bogunovic, M., Abel, M., Leboeuf, M., Helft, J., et al.: Blood-derived dermal langerin + dendritic cells survey the skin in the steady state. J Exp Med 204, 3133–3146 (2007)
Poulin, L.F., Henri, S., de Bovis, B., Devilard, E., Kissenpfennig, A., Malissen, B.: The dermis contains langerin + dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 204, 3119–3131 (2007)
Romani, N., Koide, S., Crowley, M., Witmer-Pack, M., Livingstone, A.M., Fathman, C.G., et al.: Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 169, 1169–1178 (1989)
Stoitzner, P., Tripp, C.H., Eberhart, A., Price, K.M., Jung, J.Y., Bursch, L., et al.: Langerhans cells cross-present antigen derived from skin. Proc. Natl. Acad. Sci. U. S. A. 103, 7783–7788 (2006)
Stoitzner, P., Green, L.K., Jung, J.Y., Price, K.M., Tripp, C.H., Malissen, B., et al.: Tumor immunotherapy by epicutaneous immunization requires langerhans cells. J Immunol 180, 1991–1998 (2008)
Cunningham, A.L., Carbone, F., Geijtenbeek, T.B.: Langerhans cells and viral immunity. Eur J Immunol 38, 2377–2385 (2008)
Kautz-Neu, K., Meyer, R.G., Clausen, B.E., von Stebut, E.: Leishmaniasis, contact hypersensitivity and graft-versus-host disease: understanding the role of dendritic cell subsets in balancing skin immunity and tolerance. Exp Dermatol 19, 760–771 (2010)
Bennett, C.L., van Rijn, E., Jung, S., Inaba, K., Steinman, R.M., Kapsenberg, M.L., et al.: Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 169, 569–576 (2005)
Stoecklinger, A., Eticha, T.D., Mesdaghi, M., Kissenpfennig, A., Malissen, B., Thalhamer, J., et al.: Langerin + dermal dendritic cells are critical for CD8+ T cell activation and IgH gamma-1 class switching in response to gene gun vaccines. J Immunol 186, 1377–1383 (2011)
Angel, C.E., Lala, A., Chen, C.J., Edgar, S.G., Ostrovsky, L.L., Dunbar, P.R.: CD14+ antigen-presenting cells in human dermis are less mature than their CD1a + counterparts. Int Immunol 19, 1271–1279 (2007)
Angel, C.E., Chen, C.J., Horlacher, O.C., Winkler, S., John, T., Browning, J., et al.: Distinctive localization of antigen-presenting cells in human lymph nodes. Blood 113, 1257–1267 (2009)
Klechevsky, E., Morita, R., Liu, M., Cao, Y., Coquery, S., Thompson-Snipes, L., et al.: Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29, 497–510 (2009)
van der Aar, A.M., de Groot, R., Sanchez-Hernandez, M., Taanman, E.W., van Lier, R.A., Teunissen, M.B., et al.: Cutting edge: virus selectively primes human langerhans cells for CD70 expression promoting CD8+ T cell responses. J Immunol 187, 3488–3492 (2011)
Garland, M., Migalska, K., Mahmood, T.M.T., Singh, T.R.R., Woolfson, A.D., Donnelly, R.: Microneedle arrays as medical devices for enhanced transdermal drug delivery. Expert Rev Med Devices 8, 459–482 (2011)
Donnelly, R., Majithiya, R., Singh, T., Morrow, D., Garland, M., Demir, Y.: Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm Res 28, 41–57 (2011)
Chen, X., Fernando, G.J.P., Crichton, M., Flaim, C., Yukiko, S., Corbett, H.J., et al.: Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization. J Controlled Release. 152, 349–355 (2011)
Henry, S., McAllister, D.V., Allen, M.G., Prausnitz, M.R.: Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci 87, 922–925 (1998)
Prausnitz, M., Mikszta, J., Cormier, M., Andrianov, A.: Microneedle-based vaccines. Curr Top Microbiol Immunol 333, 369–393 (2009)
Donnelly, R., Raj Singh, T.R., Woolfson, A.D.: Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv 17, 187–207 (2010)
Zhou, C., Liu, Y., Wang, H., Zhang, P., Zhang, J.: Transdermal delivery of insulin using microneedle rollers in vivo. Int J Pharm 392, 127–133 (2010)
Ding, Z., Verbaan, F.J., Bivas- Benita, M., Bungener, L., Huckriede, A., Kersten, G., et al.: Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. J Controlled Release. 136, 71–78 (2009)
Ding, Z., Van Riet, E., Romeijn, S., Kersten, G.F.A., Jiskoot, W., Bouwstra, J.A.: Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatment. Pharm Res 26, 1635–1643 (2009)
Bal, S.M., Slütter, B., van Riet, E., Kruithof, A.C., Ding, Z., Kersten, G.F.A., et al.: Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations. J Controlled Release. 142, 374–383 (2010)
Bhowmik, T., D’Souza, B., Shashidharamurthy, R., Oettinger, C., Selvaraj, P., D’Souza, M.: A novel microparticulate vaccine for melanoma cancer using transdermal delivery. J Microencapsul 28, 294–300 (2011)
Cleary, G.: Microneedles for drug delivery. Pharm Res 28, 1–6 (2011)
Shah, U.U., Roberts, M., Orlu Gul, M., Tuleu, C., Beresford, M.W.: Needle-free and microneedle drug delivery in children: a case for disease-modifying antirheumatic drugs (DMARDs). Int J Pharm 416, 1–11 (2011)
Kim, Y., Quan, F., Compans, R.W., Kang, S., Prausnitz, M.R.: Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Controlled Release. 142, 187–195 (2010)
Hiraishi, Y., Nandakumar, S., Choi, S., Lee, J., Kim, Y., Prausnitz, M.R., et al.: Bacillus Calmette-Guérin vaccination using a microneedle patch. Vaccine 29, 2626–2636 (2011)
Weldon, W., Martin, M., Zarnitsyn, V., Wang, B., Koutsonanos, D., Skountzou, I.: Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity. Clinical and vaccine immunol. 18, 647–654 (2011)
Prow, T.: Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. Small 6, 1776–1784 (2010)
Corbett, H., Chen, X., Frazer, I.: Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model. PLoS One 5, e13460 (2010)
Fernando, G.J.P., Chen, X., Prow, T., Crichton, M., Fairmaid, E.: Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PLoS One 5, e10266 (2010)
Matriano, J., Cormier, M., Johnson, J., Young, W., Buttery, M., Cormier, M., et al.: Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res 19, 63–70 (2002)
Widera, G., Johnson, J., Kim, L., Libiran, L., Nyam, K., Daddona, P.E., et al.: Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 24, 1653–1664 (2006)
Escobar-Chvez, J., Bonilla- Martinez, D., Villegas-González, M.A., Molina Trinidad, E., Casas Alancaster, N., et al.: Microneedles: a valuable physical enhancer to increase transdermal drug delivery. J Clin Pharmacol 51, 964–977 (2011)
Amorij, J., Frijlink, H., Wilschut, J., Huckriede, A.: Needle-free influenza vaccination. Lancet Infect Dis 10, 699–711 (2010)
Wang, P., Cornwell, M., Hill, J., Prausnitz, M.: Precise microinjection into skin using hollow microneedles. J Invest Dermatol 126, 1080–1087 (2006)
Frost, G.I.: Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration. Expert Opin Drug Deliv 4, 427–440 (2007)
Bal, S., Ding, Z., van Riet, E., Jiskoot, W., Bouwstra, J.: Advances in transcutaneous vaccine delivery: Do all ways lead to Rome? J Controlled Release. 148, 266–282 (2010)
Van Damme, P., Oosterhuis-Kafeja, F., Van der Wielen, M., Almagor, Y., Sharon, O., Levin, Y.: Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27, 454–459 (2009)
Alarcon, J., Hartley, A., Harvey, N., Mikszta, J.: Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol 14, 375–381 (2007)
Mikszta, J., Dekker, J., Harvey, N., Dean, C., Brittingham, J., Huang, J., et al.: Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun 74, 6806–6810 (2006)
Sullivan, S., Koutsonanos, D., Del Pilar Martin, M., Lee, J., Zarnitsyn, V., Compans, R.W., et al.: Dissolving polymer microneedle patches for influenza vaccination. Nat Med 16, 915–920 (2010)
Raphael, A., Prow, T., Crichton, M., Chen, X., Fernando, G.J.P., Prow, T.: Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays. Small 6, 1785–1793 (2010)
Chabri, F., Bouris, K., Jones, T., Barrow, D., Hann, A., Allender, C., et al.: Microfabricated silicon microneedles for nonviral cutaneous gene delivery. Br J Dermatol 150, 869–877 (2004)
Prow, T.W., Chen, X., Prow, N.A., Fernando, G.J., Tan, C.S., Raphael, A.P., et al.: Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. Small 16, 1776–1784 (2010)
Birchall, J., Coulman, S., Pearton, M., Allender, C., Brain, K., Coulman, S., et al.: Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch micro-fabricated micro-needles. J Drug Target 13, 415–421 (2005)
Coulman, S.A., Barrow, D., Anstey, A., Gateley, C., Morrissey, A., Wilke, N., et al.: Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. Curr Drug Deliv 3, 65–75 (2006)
Pearton, M., Allender, C., Brain, K., Anstey, A., Gateley, C., Wilke, N., et al.: Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations. Pharm Res 25, 407–416 (2008)
Gill, H.S., Soderholm, J., Prausnitz, M.R., Sallberg, M., Sderholm, J., Sllberg, M.: Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther 17, 811–814 (2010)
Choi, S. O., Park, J. H., Gill, H. S., Choi, Y., Allen, M.G., M. R.: Prausnitz. Microneedles electrode array for electroporation of skin for gene therapy. Controlled Release Society 32nd Annual Meeting & Exposition Transactions. 318 (2005)
Hooper, J., Golden, J., Ferro, A., King, A.: Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine 25, 1814–1823 (2007)
Daugimont, L., Baron, N., Vandermeulen, G., Pavselj, N., Miklavcic, D., Jullien, M., et al.: Hollow microneedle arrays for intradermal drug delivery and DNA electroporation. J Membr Biol 236, 117–125 (2010)
Levine, M.M., Sztein, M.B.: Vaccine development strategies for improving immunization: the role of modern immunology. Nat Immunol 5, 460–464 (2004)
Soppimath, K.S., Aminabhavi, T.M., Kulkarni, A.R., Rudzinski, W.E.: Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70, 1–20 (2001)
Delie, F., Blanco-Prieto, M.J.: Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules 10, 65–80 (2005)
McCarron, P.A., Donnelly, R.F., Marouf, W.: Celecoxib-loaded poly(D, L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure. J Microencapsul 23, 480–498 (2006)
Eniola, A.O., Hammer, D.A.: Artificial polymeric cells for targeted drug delivery. J Control Release 87, 15–22 (2003)
Jaganathan, K.S., Vyas, S.P.: Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine 24, 201–4211 (2006)
Gutierro, I., Hernandez, R.M., Igartua, M., Gascon, A.R., Pedraz, J.L.: Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine 21, 67–77 (2002)
Lu, D., Garcia-Contreras, L., Xu, D., Kurtz, S.L., Liu, J., Braunstein, M., et al.: Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B. Pharm Res 24, 1834–1843 (2007)
Sharp, F.A., Ruane, D., Claass, B., Creagh, E., Harris, J., Malyala, P., et al.: Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc. Natl. Acad. Sci. U. S. A. 106, 870–875 (2009)
de Jalon, E.G., Blanco-Prieto, M.J., Ygartua, P., Santoyo, S.: PLGA microparticles: possible vehicles for topical drug delivery. Int J Pharm 226, 181–184 (2001)
Jenning, V., Gysler, A., Schafer-Korting, M., Gohla, S.H.: Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 49, 211–218 (2000)
Alvarez-Roman, R., Naik, A., Kalia, Y.N., Guy, R.H., Fessi, H.: Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 21, 1818–1825 (2004)
Alvarez-Roman, R., Naik, A., Kalia, Y.N., Guy, R.H., Fessi, H.: Skin penetration and distribution of polymeric nanoparticles. J Control Release 99, 53–62 (2004)
Luengo, J., Weiss, B., Schneider, M., Ehlers, A., Stracke, F., Konig, K., et al.: Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol 19, 190–197 (2006)
Lademann, J., Richter, H., Teichmann, A., Otberg, N., Blume-Peytavi, U., Luengo, J., et al.: Nanoparticles–an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 66, 159–164 (2007)
Toll, R., Jacobi, U., Richter, H., Lademann, J., Schaefer, H., Blume-Peytavi, U.: Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 123, 168–176 (2004)
Coulman, S.A., Anstey, A., Gateley, C., Morrissey, A., McLoughlin, P., Allender, C., et al.: Microneedle mediated delivery of nanoparticles into human skin. Int J Pharm Jan. 366, 190–200 (2009)
McAllister, D.V., Wang, P.M., Davis, S.P., Park, J.H., Canatella, P.J., Allen, M.G., et al.: Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc. Natl. Acad. Sci. U. S. A. 100, 13755–13760 (2003)
Bal, S.M., Slutter, B., Jiskoot, W., Bouwstra, J.A.: Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation. Vaccine 29, 4025–4032 (2011)
Ueno, H., Schmitt, N., Klechevsky, E., Pedroza-Gonzalez, A., Matsui, T., Zurawski, G., et al.: Harnessing human dendritic cell subsets for medicine. Immunol Rev 234, 199–212 (2010)
Birchall, J.C., Clemo, R., Anstey, A., John, D.N.: Microneedles in clinical practice–an exploratory study into the opinions of healthcare professionals and the public. Pharm Res 28, 95–106 (2011)
Donnelly, R.F., Singh, T.R., Tunney, M.M., Morrow, D.I., McCarron, P.A., O’Mahony, C., Woolfson, A.D.: Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res 26, 2513–2522 (2009)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Donnelly, R.F., Al-Zahrani, S., Zaric, M., McCrudden, C.M., Scott, C.J., Kissenpfenning, A. (2014). Vaccine Delivery Using Microneedles. In: Giese, M. (eds) Molecular Vaccines. Springer, Cham. https://doi.org/10.1007/978-3-319-00978-0_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-00978-0_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-00977-3
Online ISBN: 978-3-319-00978-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)